MIR100HG
geneOn this page
Also known as AGD1lncRNA-N2linc-NeD125
Summary
MIR100HG (mir-100-let-7a-2-mir-125b-1 cluster host gene, HGNC:39522) is a long non-coding RNA gene on chromosome 11q24.1.
This gene produces long non-coding RNAs that act as regulators of cell proliferation. Alternative promoter usage and splicing results in multiple transcript variants. Some transcript variants may promote growth, while others may act to negatively regulate cell division.
Source: NCBI Gene 399959 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:39522 |
| Approved symbol | MIR100HG |
| Name | mir-100-let-7a-2-mir-125b-1 cluster host gene |
| Location | 11q24.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | AGD1, lncRNA-N2, linc-NeD125 |
| Ensembl gene | ENSG00000255248 |
| Ensembl biotype | lncRNA |
| OMIM | 615965 |
| Entrez | 399959 |
| RNAcentral | URS0000A76E00 — lncRNA, 3129 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 246 — 246 lncRNA
ENST00000524376, ENST00000526674, ENST00000527100, ENST00000527474, ENST00000528381, ENST00000528986, ENST00000529733, ENST00000529804, ENST00000529823, ENST00000530072, ENST00000530955, ENST00000531071, ENST00000531381, ENST00000531470, ENST00000531629, ENST00000532315, ENST00000532319, ENST00000532350, ENST00000532890, ENST00000533109, ENST00000534195, ENST00000534297, ENST00000534782, ENST00000636654, ENST00000637700, ENST00000647591, ENST00000647749, ENST00000647967, ENST00000648082, ENST00000648084, ENST00000648163, ENST00000648209, ENST00000648213, ENST00000648576, ENST00000648734, ENST00000649216, ENST00000649293, ENST00000649544, ENST00000649626, ENST00000650497, ENST00000653167, ENST00000653565, ENST00000654519, ENST00000654571, ENST00000654629, ENST00000655138, ENST00000655232, ENST00000655288, ENST00000655814, ENST00000656226, ENST00000656387, ENST00000656682, ENST00000656793, ENST00000656868, ENST00000657554, ENST00000657990, ENST00000658183, ENST00000658364, ENST00000658452, ENST00000659296, ENST00000659378, ENST00000660148, ENST00000660311, ENST00000660329, ENST00000660603, ENST00000661432, ENST00000661695, ENST00000661848, ENST00000662950, ENST00000663296, ENST00000663802, ENST00000664908, ENST00000665051, ENST00000665305, ENST00000665519, ENST00000665673, ENST00000666085, ENST00000666347, ENST00000666485, ENST00000667484, ENST00000668776, ENST00000669306, ENST00000669472, ENST00000669993, ENST00000670198, ENST00000670374, ENST00000670396, ENST00000670520, ENST00000670843, ENST00000670951, ENST00000686059, ENST00000686772, ENST00000688615, ENST00000689894, ENST00000690059, ENST00000690151, ENST00000690198, ENST00000690515, ENST00000691884, ENST00000692610, ENST00000693154, ENST00000701811, ENST00000701835, ENST00000702205, ENST00000702309, ENST00000702516, ENST00000702652, ENST00000702800, ENST00000763196, ENST00000780376, ENST00000780377, ENST00000780378, ENST00000780379, ENST00000780380, ENST00000780381, ENST00000780382, ENST00000780383, ENST00000780384, ENST00000780385, ENST00000780386, ENST00000780387, ENST00000780388, ENST00000780389, ENST00000780390, ENST00000780391, ENST00000780392, ENST00000780393, ENST00000780394, ENST00000780395, ENST00000780396, ENST00000780397, ENST00000780398, ENST00000780399, ENST00000780400, ENST00000780401, ENST00000780402, ENST00000780403, ENST00000780404, ENST00000780405, ENST00000780406, ENST00000780407, ENST00000780408, ENST00000780409, ENST00000780410, ENST00000780411, ENST00000780412, ENST00000780413, ENST00000780414, ENST00000780415, ENST00000780416, ENST00000780417, ENST00000780418, ENST00000780419, ENST00000780420, ENST00000780421, ENST00000780422, ENST00000780423, ENST00000780424, ENST00000780425, ENST00000780426, ENST00000780427, ENST00000780428, ENST00000780429, ENST00000780430, ENST00000780431, ENST00000780432, ENST00000780433, ENST00000780434, ENST00000780435, ENST00000780436, ENST00000780437, ENST00000780438, ENST00000780439, ENST00000780440, ENST00000780441, ENST00000780442, ENST00000780443, ENST00000780444, ENST00000780445, ENST00000780446, ENST00000780447, ENST00000780448, ENST00000780449, ENST00000780450, ENST00000780451, ENST00000780452, ENST00000780453, ENST00000780454, ENST00000780455, ENST00000780456, ENST00000780457, ENST00000780458, ENST00000780459, ENST00000780460, ENST00000780461, ENST00000780462, ENST00000780463, ENST00000780464, ENST00000780465, ENST00000780466, ENST00000780467, ENST00000780468, ENST00000780469, ENST00000780470, ENST00000780471, ENST00000780472, ENST00000780473, ENST00000780474, ENST00000780475, ENST00000780476, ENST00000780477, ENST00000780478, ENST00000780479, ENST00000780480, ENST00000780481, ENST00000780482, ENST00000780483, ENST00000780484, ENST00000780485, ENST00000780486, ENST00000780487, ENST00000780488, ENST00000780489, ENST00000780490, ENST00000780491, ENST00000780492, ENST00000780493, ENST00000780494, ENST00000780495, ENST00000780496, ENST00000780497, ENST00000780498, ENST00000780499, ENST00000780500, ENST00000780501, ENST00000780502, ENST00000780503, ENST00000780504, ENST00000780505, ENST00000780506, ENST00000780507, ENST00000780508, ENST00000780509, ENST00000780510, ENST00000780511, ENST00000780512
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000524376 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002200195 | 122089103 | 122091719 |
| ENSE00004151827 | 122100374 | 122100501 |
Expression profiles
Bgee: expression breadth ubiquitous, 245 present calls, max score 99.08.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 59.7702 / max 1464.0687, expressed in 1231 samples.
FANTOM5 promoters (50 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 122811 | 23.7529 | 1006 |
| 122819 | 4.3189 | 636 |
| 122812 | 3.0949 | 845 |
| 122849 | 2.7556 | 597 |
| 122814 | 2.6721 | 692 |
| 122820 | 2.5387 | 546 |
| 122843 | 2.5174 | 513 |
| 122847 | 1.6853 | 524 |
| 122853 | 1.4695 | 559 |
| 122846 | 1.4493 | 544 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 99.08 | gold quality |
| ganglionic eminence | UBERON:0004023 | 98.95 | gold quality |
| cartilage tissue | UBERON:0002418 | 98.90 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 98.36 | gold quality |
| cortical plate | UBERON:0005343 | 98.32 | gold quality |
| right coronary artery | UBERON:0001625 | 98.08 | gold quality |
| ascending aorta | UBERON:0001496 | 98.05 | gold quality |
| thoracic aorta | UBERON:0001515 | 98.04 | gold quality |
| sural nerve | UBERON:0015488 | 97.69 | gold quality |
| caput epididymis | UBERON:0004358 | 97.65 | gold quality |
| left ovary | UBERON:0002119 | 97.52 | gold quality |
| right ovary | UBERON:0002118 | 97.30 | gold quality |
| stromal cell of endometrium | CL:0002255 | 97.16 | gold quality |
| calcaneal tendon | UBERON:0003701 | 96.83 | gold quality |
| right uterine tube | UBERON:0001302 | 96.55 | gold quality |
| corpus epididymis | UBERON:0004359 | 96.54 | gold quality |
| aorta | UBERON:0000947 | 96.34 | gold quality |
| endocervix | UBERON:0000458 | 96.27 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 96.20 | gold quality |
| coronary artery | UBERON:0001621 | 96.19 | gold quality |
| left coronary artery | UBERON:0001626 | 96.17 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 96.08 | gold quality |
| left uterine tube | UBERON:0001303 | 96.06 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 96.02 | gold quality |
| lower esophagus | UBERON:0013473 | 95.96 | gold quality |
| ovary | UBERON:0000992 | 95.77 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.58 | gold quality |
| caudate nucleus | UBERON:0001873 | 95.32 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.30 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.21 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 47.61 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 14)
- Tag single nucleotide polymorphisms near the BLID and LOC399959 genes are not susceptibility loci for high myopia in the Chinese Han population. (PMID:21031016)
- This study reveals an unprecedented function of long non-coding RNAs MONC and MIR100HG as regulators of hematopoiesis and oncogenes in the development of myeloid leukemia. (PMID:25027842)
- Linc-NeD125 represents the host gene for miR-125b-1, a microRNA with an established role as negative regulator of human neuroblastoma cell proliferation. (PMID:26480000)
- TGF-beta induces MIR100HG lncRNA, encoding miR-100, let-7a and miR-125b that control pancreatic ductal adenocarcinoma tumorigenesis. Pro-tumorigenic miR-100 and miR-125b increase and anti-tumorigenic let-7a is unchanged, as TGF-beta also induces LIN28B. The induction of LIN28B results in the up-regulation of miR-100 and miR-125b, with let-7a unchanged despite being part of the same MIR100HG primary transcript. (PMID:29748571)
- MIR100HG rs1816158 was associated with overall survival in oral cavity cancer. Expression of miR-100 was associated with overall survival in an independent cohort of head and neck squamous cell carcinoma (HNSCC) cases. (PMID:29880533)
- MIR100HG formed a triplex structure with p27. Through regulating the expression of p27, MIR100HG promoted cell proliferation in TNBC. Increased expression of MIR100HG was associated with poor prognosis. (PMID:30042378)
- We conclude that MIR100HG potentially serves as a binding platform for both HuR and its target mRNAs, thus modulating HuR-target mRNA interaction (PMID:30102375)
- ELK1-induced up-regulation of MIR100HG promoted osteosarcoma progression by epigenetically silencing LATS1 and LATS2. (PMID:30551532)
- The study in vitro suggested down-regulation of MIR100HG expression inhibits cell proliferation, migration, and invasion in gastric cancer. In conclusion, MIR100HG is a credible prognostic biomarker and functions as an oncogenic lncRNA in gastric cancer. (PMID:30886062)
- Constitutive beta-Catenin Overexpression Represses Lncrna MIR100HG Transcription via HDAC6-Mediated Histone Modification in Colorectal Cancer. (PMID:35247921)
- Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m(6)A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression. (PMID:35279145)
- A concise review on the role of MIR100HG in human disorders. (PMID:37487022)
- LncRNA MIR100HG Promotes Cell Proliferation in Nasopharyngeal Carcinoma by Targeting miR-136-5p/IL-6 Axis. (PMID:38278928)
- LncRNA MIR100HG affects the proliferation and metastasis of lung cancer cells through mediating the microRNA-5590-3p/DCBLD2 axis. (PMID:38602284)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): rheumatic heart disease